These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36849269)

  • 1. Commentary: Sublobar resection for ground-glass opacity: Is less really more?
    Steimer D; Ugalde Figueroa P
    J Thorac Cardiovasc Surg; 2023 Oct; 166(4):1232-1233. PubMed ID: 36849269
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary: Less is maybe more: Sublobar resection in screen-detected lung cancers.
    Giffin C; Kidane B
    J Thorac Cardiovasc Surg; 2022 Jun; 163(6):1917-1918. PubMed ID: 34482957
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sublobar curative resection for non-small-cell lung cancer].
    Bonnette P
    Bull Cancer; 2012 Nov; 99(11):1069-75. PubMed ID: 23092959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary: Is sublobar resection enough for ground-glass opacity-dominant lung adenocarcinoma?
    Zhang Y; Chen H
    J Thorac Cardiovasc Surg; 2022 Jan; 163(1):303-304. PubMed ID: 33158561
    [No Abstract]   [Full Text] [Related]  

  • 5. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
    Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non-small cell lung cancer.
    Nakata M; Sawada S; Yamashita M; Saeki H; Kurita A; Takashima S; Tanemoto K
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1226-31. PubMed ID: 15942561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary: Toward precision surgery: Advances in defining sublobar resection candidacy.
    Giles AE; Kidane B
    J Thorac Cardiovasc Surg; 2022 May; 163(5):1666-1667. PubMed ID: 34340851
    [No Abstract]   [Full Text] [Related]  

  • 9. Sublobar Resection Margin Width Does Not Affect Recurrence of Clinical N0 Non-small Cell Lung Cancer Presenting as GGO-Predominant Nodule of 3 cm or Less.
    Moon Y; Lee KY; Moon SW; Park JK
    World J Surg; 2017 Feb; 41(2):472-479. PubMed ID: 27718002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could less be more?-A systematic review and meta-analysis of sublobar resections versus lobectomy for non-small cell lung cancer according to patient selection.
    Cao C; Chandrakumar D; Gupta S; Yan TD; Tian DH
    Lung Cancer; 2015 Aug; 89(2):121-32. PubMed ID: 26033208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublobar resection versus lobectomy in solid-type, clinical stage IA, non-small cell lung cancer.
    Jeon HW; Kim YD; Kim KS; Sung SW; Park HJ; Park JK
    World J Surg Oncol; 2014 Jul; 12():215. PubMed ID: 25027055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of thoracoscopic anatomical sublobar resection under 3-dimensional computed tomography simulation.
    Hamada A; Oizumi H; Kato H; Suzuki J; Nakahashi K; Takamori S; Sho R; Sadahiro M
    Surg Endosc; 2022 Apr; 36(4):2312-2320. PubMed ID: 33881626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small cell lung cancer: when to offer sublobar resection.
    Sihoe AD; Van Schil P
    Lung Cancer; 2014 Nov; 86(2):115-20. PubMed ID: 25249427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).
    Altorki NK; Wang X; Wigle D; Gu L; Darling G; Ashrafi AS; Landrenau R; Miller D; Liberman M; Jones DR; Keenan R; Conti M; Wright G; Veit LJ; Ramalingam SS; Kamel M; Pass HI; Mitchell JD; Stinchcombe T; Vokes E; Kohman LJ
    Lancet Respir Med; 2018 Dec; 6(12):915-924. PubMed ID: 30442588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of sublobar resection for c-stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET.
    Yoshioka M; Ichiguchi O
    Ann Thorac Cardiovasc Surg; 2009 Apr; 15(2):82-8. PubMed ID: 19471220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral pure ground-glass opacity: segmentectomy versus wedge resection.
    Luo T; Chen Q; Zeng J; Cai L; Huang X
    J Cardiothorac Surg; 2021 Sep; 16(1):260. PubMed ID: 34521432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublobar resection for early-stage lung cancer: the issue of safety margins.
    Gossot D; Lafouasse C; Kovacs E; Seguin-Givelet A
    Eur J Cardiothorac Surg; 2023 Mar; 63(3):. PubMed ID: 36810786
    [No Abstract]   [Full Text] [Related]  

  • 18. A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer.
    Suzuki K; Watanabe SI; Wakabayashi M; Saji H; Aokage K; Moriya Y; Yoshino I; Tsuboi M; Nakamura S; Nakamura K; Mitsudomi T; Asamura H;
    J Thorac Cardiovasc Surg; 2022 Jan; 163(1):289-301.e2. PubMed ID: 33487427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally Invasive and Sublobar Resections for Lung Cancer.
    Godfrey CM; Marmor HN; Lambright ES; Grogan EL
    Surg Clin North Am; 2022 Jun; 102(3):483-492. PubMed ID: 35671768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stepwise flowchart for decision making on sublobar resection through the estimation of spread through air space in early stage lung cancer
    Suh JW; Jeong YH; Cho A; Kim DJ; Chung KY; Shim HS; Lee CY
    Lung Cancer; 2020 Apr; 142():28-33. PubMed ID: 32065918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.